Grant: Catalyst Grant: Pandemic Preparedness
University of Ottawa
$99,527.00
The role of sialyltransferases in generating influenza receptors
FY 2009-10
Summary
Neuraminidase inhibitors are a class of drugs being stockpiled for use as a first-line of defense to contain a new influenza A virus pandemic until an effective vaccine can be produced. In recent years, influenza A viruses have appeared that are resistant to these drugs. Also, during an influenza pandemic, large-scale use of drugs is likely to select rapidly for drug-resistant viruses, which would seriously compromise the long-term effectiveness of these antivirals. Therefore, there is a need to develop new anti-influenza virus agents. To initiate an infection, influenza virus must bind to sialic acid, a sugar that is attached to molecules on the outer surface of cells. Enzymes called sialyltransferases are responsible for adding sialic acid to cell surface molecules. There are at least 18 different human sialyltransferases and it is not known which of these enzymes are responsible for adding sialic acid to the molecules to which influenza A virus binds - the influenza virus receptors. Our research is designed to identify the sialyltransferases that generate the influenza virus receptors. This knowledge can be used to design drugs that block activity of the sialyltransferases and the formation of the influenza A virus receptors. Our research also has the potential to identify the influenza virus receptors themselves, which also become targets for the development of new drugs for the treatment of influenza virus infections.
Department
Program
Catalyst Grant: Pandemic Preparedness
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
182540
Name
Dimock Kenneth D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Pandemic Preparedness
Projecttitle
The role of sialyltransferases in generating influenza receptors
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$99,527
Cihrequipment2
$0
Programname2
Catalyst Grant: Pandemic Preparedness
Keyworddelim
Drug Targets; Influenza A Virus; Knockout Mice; Receptors; Rna Interference; Sialic Acid
Abstract
Neuraminidase inhibitors are a class of drugs being stockpiled for use as a first-line of defense to contain a new influenza A virus pandemic until an effective vaccine can be produced. In recent years, influenza A viruses have appeared that are resistant to these drugs. Also, during an influenza pandemic, large-scale use of drugs is likely to select rapidly for drug-resistant viruses, which would seriously compromise the long-term effectiveness of these antivirals. Therefore, there is a need to develop new anti-influenza virus agents. To initiate an infection, influenza virus must bind to sialic acid, a sugar that is attached to molecules on the outer surface of cells. Enzymes called sialyltransferases are responsible for adding sialic acid to cell surface molecules. There are at least 18 different human sialyltransferases and it is not known which of these enzymes are responsible for adding sialic acid to the molecules to which influenza A virus binds - the influenza virus receptors. Our research is designed to identify the sialyltransferases that generate the influenza virus receptors. This knowledge can be used to design drugs that block activity of the sialyltransferases and the formation of the influenza A virus receptors. Our research also has the potential to identify the influenza virus receptors themselves, which also become targets for the development of new drugs for the treatment of influenza virus infections.
Competitiondate
200904
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dimock, Kenneth D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $99,527~ $0~